J Guerrin

421 total citations
43 papers, 332 citations indexed

About

J Guerrin is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J Guerrin has authored 43 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Pathology and Forensic Medicine and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J Guerrin's work include Cancer Treatment and Pharmacology (8 papers), Chemotherapy-induced organ toxicity mitigation (6 papers) and Cancer-related Molecular Pathways (4 papers). J Guerrin is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Chemotherapy-induced organ toxicity mitigation (6 papers) and Cancer-related Molecular Pathways (4 papers). J Guerrin collaborates with scholars based in France and United States. J Guerrin's co-authors include P. Fargeot, C. De Gislain, Monique Dumas, G Mathé, Sarab Lizard‐Nacol, Jean Cuisenier, R Plagne, J. L. Misset, Philippe d’Athis and P. Chollet and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Cancer.

In The Last Decade

J Guerrin

43 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Guerrin France 10 187 132 112 63 49 43 332
S Schryber United States 8 258 1.4× 82 0.6× 107 1.0× 43 0.7× 76 1.6× 9 435
Tomio Wada Japan 8 163 0.9× 57 0.4× 113 1.0× 64 1.0× 75 1.5× 12 438
Dìlek Dìnçol Türkiye 10 143 0.8× 79 0.6× 46 0.4× 56 0.9× 73 1.5× 28 394
R Nissen-Meyer Norway 13 306 1.6× 91 0.7× 259 2.3× 66 1.0× 33 0.7× 38 556
Mary E. Sears United States 6 262 1.4× 47 0.4× 189 1.7× 18 0.3× 42 0.9× 10 363
Erik Sandberg Denmark 8 296 1.6× 125 0.9× 84 0.8× 234 3.7× 19 0.4× 10 444
Antman Kh United States 8 140 0.7× 51 0.4× 38 0.3× 52 0.8× 26 0.5× 9 343
Yukitoshi AOKI Japan 6 143 0.8× 50 0.4× 76 0.7× 50 0.8× 52 1.1× 12 386
M.A. Raja Saudi Arabia 14 252 1.3× 98 0.7× 157 1.4× 109 1.7× 50 1.0× 21 436
Anne-Birgitte Jacobsen Norway 13 184 1.0× 78 0.6× 84 0.8× 196 3.1× 45 0.9× 30 452

Countries citing papers authored by J Guerrin

Since Specialization
Citations

This map shows the geographic impact of J Guerrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Guerrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Guerrin more than expected).

Fields of papers citing papers by J Guerrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Guerrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Guerrin. The network helps show where J Guerrin may publish in the future.

Co-authorship network of co-authors of J Guerrin

This figure shows the co-authorship network connecting the top 25 collaborators of J Guerrin. A scholar is included among the top collaborators of J Guerrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Guerrin. J Guerrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lizard‐Nacol, Sarab, et al.. (1997). Loss of heterozygosity at theTP53 gene: Independent occurrence from genetic instability events in node-negative breast cancer. International Journal of Cancer. 72(4). 599–603. 9 indexed citations
2.
Lizard‐Nacol, Sarab, Bruno Coudert, Jean‐Marc Riedinger, P. Fargeot, & J Guerrin. (1997). p53 gene alterations are associated with a decreased responsiveness to neoadjuvant chemotherapy in human breast cancer. International Journal of Oncology. 10(6). 1203–7. 7 indexed citations
3.
4.
Lizard‐Nacol, Sarab, Rosette Lidereau, François Collin, et al.. (1995). Benign breast disease: absence of genetic alterations at several loci implicated in breast cancer malignancy.. PubMed. 55(19). 4416–9. 31 indexed citations
5.
Lizard‐Nacol, Sarab, et al.. (1994). [Amplification of c-myc and c-erbbeta-2(HER-2/neu) in breast cancer without axillary lymph node metastasis: correlation with other prognostic parameters].. PubMed. 81(9). 780–4. 1 indexed citations
6.
Dumas, Monique, et al.. (1990). Influence of hydration on ultrafilterable platinum kinetics and kidney function in patients treated withcis-diamminedichloroplatinum(II). Cancer Chemotherapy and Pharmacology. 26(4). 278–282. 16 indexed citations
7.
Friedman, Sam, et al.. (1989). Non-Hodgkin's lymphoma of the urethra: A rare extranodal entity. Gynecologic Oncology. 35(1). 110–111. 15 indexed citations
8.
Dumas, Monique, et al.. (1989). Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum. Cancer Chemotherapy and Pharmacology. 23(1). 37–40. 12 indexed citations
9.
Friedman, Stephen, et al.. (1988). A Clinico-Pathological and Prognostic Analysis of Non-Hodgkin Lymphoma: A study of 203 patients. Acta Oncologica. 27(5). 489–495. 8 indexed citations
10.
Farmer, Mildred V., et al.. (1988). Proton Nuclear Magnetic Resonance Spectroscopy of Plasma Lipoproteins in Malignancy. Acta Oncologica. 27(5). 479–482. 4 indexed citations
11.
Friedman, Stephen, et al.. (1987). Modification of Kiel and working formulation classifications for improved survival prediction in non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 5(10). 1634–1639. 11 indexed citations
12.
Dumas, Monique, P D’Athis, C. De Gislain, et al.. (1985). Model independent pharmacokinetic study of cis-dichlorodiammineplatinum (II).. PubMed. 23(8). 430–3. 9 indexed citations
13.
Fargeot, P. & J Guerrin. (1984). [Role of chemotherapy in adjuvant treatment of breast cancer: modulation of the immune status].. PubMed. 71(4). 346–53. 1 indexed citations
14.
Chauvergne, J, N.B. Bui, P Cappelaere, et al.. (1982). [Chemotherapy in advanced malignant melanoma. Results of a controlled trial comparing a combination of dacarbazine (DTIC) and detorubicin with dacarbazine alone].. PubMed. 58(46). 2697–701. 7 indexed citations
15.
Chauvergne, J, et al.. (1977). [Polychemotherapy of advanced breast cancer. Triple combination with doxorubicin. Analysis of 209 observation].. PubMed. 64(4). 667–80. 2 indexed citations
16.
17.
Guerrin, J, et al.. (1972). Dosage radio-immunologique de l'antigène carcino-embryonnaire circulant. Extraction immuno-perchlorique du sérum.. 61(12). 1 indexed citations
18.
Fortin, Martin, et al.. (1971). Valeur pratique de l'alpha-foeto-protéine dans le diagnostic et la surveillance post-opératoire des tumeurs embryonnaires du testicule. La Presse Médicale. 79(36). 3 indexed citations
19.
Cabanne, F, et al.. (1970). [Primary nevocarcinoma of the cervix uteri].. PubMed. 65(11). 649–58. 2 indexed citations
20.
Cabanne, F & J Guerrin. (1969). [Riopelle and Thériault alveolar rhabdomyosarcoma. Brief collective review apropos of a case report].. PubMed. 56(2). 187–96. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Schryber Breakdown of academic impact, for papers by Tomio Wada Breakdown of academic impact, for papers by Dìlek Dìnçol Breakdown of academic impact, for papers by R Nissen-Meyer Breakdown of academic impact, for papers by Mary E. Sears Breakdown of academic impact, for papers by Erik Sandberg Breakdown of academic impact, for papers by Antman Kh Breakdown of academic impact, for papers by Yukitoshi AOKI Breakdown of academic impact, for papers by M.A. Raja Breakdown of academic impact, for papers by Anne-Birgitte Jacobsen
Rankless by CCL
2026